“…In this paper we performed the following: 1) the release of all 1 The abbreviations used are: FCS, fetal calf serum; Neu5Ac, Nacetylneuraminic acid; Cer, ceramide; N-acylsphingosine, (2S,3R,4E)-2-amino-1,3-dihydroxy-octadecene; [1-3 H]sphingosine, (2S,3R,4E)-2-amino-1,3-dihydroxy- [1-3 H]octadecene; [1][2][3] H]sphinganine, (2S,3R)-2-amino-1,3-dihydroxy- [1-3 H]octadecane; PE, phosphatidylethanolamine; SM, sphingomyelin; BME, basal modified Eagle's medium; DMEM, Dulbecco's modified Eagle's medium; EMEM, Eagle's minimum essential medium; HPTLC, high performance thin layer chromatography; GlcCer, -Glc-(1-1)-Cer; LacCer, -Gal-(1-4)--Glc-(1-1)-Cer; GM3, II classes of sphingolipids from both normal and tumor cells in culture, 2) the association of sphingolipids released by cells with proteins and lipoproteins of FCS present in the culture medium, and 3) the fate of sphingolipids released by the cells and taken up by the same or different cells. Our results suggest that the endogenous and specific sphingolipid content of plasma membrane cannot be changed in vivo by the incorporation into cells of circulating sphingolipids, and suggest that the sphingolipids that are taken up by the cells are largely and rapidly catabolized.…”